Multiple Assemblies exist for SMTL entry 5u7k
PDE2 catalytic domain complexed with inhibitors; X-RAY DIFFRACTION 2.06 Å

	SMTL ID 5u7k.1 Ligands ZINC ION; MAGNESIUM ION; 3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-5-propoxy[1,2,4]triazolo[4,3-a]pyrazine Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7k.2 Ligands ZINC ION; MAGNESIUM ION; 3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-5-propoxy[1,2,4]triazolo[4,3-a]pyrazine Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7k.3 Ligands ZINC ION; MAGNESIUM ION; CHLORIDE ION; 3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-5-propoxy[1,2,4]triazolo[4,3-a]pyrazine Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7k.4 Ligands ZINC ION; MAGNESIUM ION; 3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-5-propoxy[1,2,4]triazolo[4,3-a]pyrazine Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer